How to differentiate viral vs bacterial infection clinically
viral AND bacterial infection diagnosis
CDC differentiate viral and bacterial infections symptoms clinical diagnosis antibiotics
| Feature | More suggestive of viral infection | More suggestive of bacterial infection |
|---|---|---|
| Onset and course | Often starts with generalized symptoms, then improves steadily over several days | May be abrupt and focal, or worsen after initial viral improvement |
| Symptoms | Cough, runny nose, hoarseness, conjunctivitis, mouth ulcers, diffuse aches, diarrhea | Localized pain and inflammation: one-sided ear/facial pain, painful urination, focal skin redness, focal chest findings |
| Fever | May be absent or present, sometimes high | May be high and persistent, but fever alone cannot distinguish |
| Secretions | Usually watery early, may become thick/yellow-green during normal recovery | Purulent material plus a compatible focal syndrome can support bacterial disease, but yellow/green mucus alone does not mean bacteria |
| Examination | Diffuse upper-airway irritation, wheeze, bilateral symptoms | Focal signs such as a tonsillar exudate with tender anterior cervical nodes, localized crackles, cellulitis, or a tender fluctuant abscess |
| Blood tests | Lymphocyte predominance can occur | Neutrophilia can occur, but both patterns overlap substantially |
| Response over time | Usually begins improving within about 5-10 days for uncomplicated respiratory viral infections | Persistent symptoms, severe symptoms, or “double worsening” may point to bacterial complication |
Create a quick-reference table for viral vs bacterial signs
viral AND bacterial diagnosis
CDC clinical symptoms viral versus bacterial infection diagnosis antibiotics
| Clinical feature | More suggestive of viral infection | More suggestive of bacterial infection |
|---|---|---|
| Typical pattern | Diffuse, multisystem symptoms | Localized infection or focal inflammation |
| Upper-respiratory symptoms | Cough, runny nose, hoarseness, conjunctivitis, mouth ulcers | Less likely to cause cough/runny nose in isolated focal illness such as strep throat |
| Onset/course | Improves gradually over days | Persistent without improvement, severe from onset, or worsens after initial improvement |
| Fever | May be absent, low, or high | May be high and persistent, but not diagnostic by itself |
| Pain | General body aches, headache, sore throat with cold symptoms | Focal pain: one-sided facial/tooth pain, ear pain, painful urination, focal chest pain, localized skin pain |
| Nasal mucus/sputum | Often watery initially; may turn yellow/green during normal recovery | Purulence plus compatible focal syndrome may support bacteria, but color alone is unreliable |
| Examination | Diffuse throat redness, wheeze, bilateral symptoms | Focal crackles/consolidation, cellulitis, abscess, marked unilateral findings, tender localized nodes |
| CBC pattern | May show lymphocyte predominance | May show neutrophilia, though overlap is common |
| Tests | Viral PCR/antigen test may confirm | Culture, rapid strep test, urinalysis/culture, or targeted imaging may confirm |
| Antibiotics | Do not treat viral infections | May be needed for proven or strongly suspected bacterial infections |
Find recent guidelines on distinguishing viral and bacterial infections
site:cdc.gov antibiotic use clinical care adult outpatient acute bronchitis pharyngitis rhinosinusitis guideline distinguishing viral bacterial
site:nice.org.uk guidance distinguishing viral bacterial infection acute respiratory infection CRP procalcitonin
respiratory infection AND practice guideline
https://www.cdc.gov/antibiotic-use/hcp/clinical-care/adult-o…
acute respiratory infection AND diagnostic tests
| Guideline/source | Current practical recommendation |
|---|---|
| CDC adult outpatient guidance | For uncomplicated acute bronchitis, focus on excluding pneumonia: abnormal vital signs or focal lung findings merit further assessment. Colored sputum does not indicate bacterial infection, and routine antibiotics are not recommended. |
| CDC: acute bacterial rhinosinusitis | Consider bacterial sinusitis if symptoms are persistent for more than 10 days without improvement, severe for over 3-4 days with fever at least 39 C plus purulent nasal discharge or facial pain, or show worsening after initial improvement. |
| CDC: pharyngitis | Clinical findings alone cannot reliably distinguish group A strep from viral pharyngitis. Use a rapid antigen detection test when indicated, rather than treating based on throat appearance alone. In adults, GAS accounts for only about 5-10% of sore throats. |
| CDC pediatric outpatient guidance | In children, viral URI commonly presents with nasal discharge/congestion or cough; discharge can change from clear during the illness. For suspected bacterial sinusitis, use the same persistent, severe, or worsening criteria. |
| NICE NG237, suspected acute respiratory infection in people over 16 | Symptoms/signs, white-cell differential, CRP, and procalcitonin can contribute to assessment but are not definitive. Rapid point-of-care microbiology tests generally lack sufficient accuracy to determine viral versus bacterial cause on their own. Viral tests for influenza/RSV can be useful as rule-in tests. |
| NICE guidance on co-infection/pneumonia | Do not interpret a high CRP as proof of bacterial infection. If pneumonia or bacterial co-infection is a concern, combine clinical assessment with appropriate imaging and microbiology, such as respiratory viral PCR, sputum/blood cultures, and urine antigen tests in selected patients. |
Find the latest pneumonia-specific guidelines
2025 2026 community acquired pneumonia clinical practice guideline adult official guideline
2025 2026 hospital acquired ventilator associated pneumonia guideline official society guideline
pneumonia AND practice guideline
https://site.thoracic.org/press-releases/treatment-with-anti…
PMID: 40614556
PMID: 40031989
"Treatment with Antibiotics and Steroids in Adults with Community-Acquired Pneumonia" 2025 guideline full title
| Population / setting | Most current guideline | Key relevance |
|---|---|---|
| Adults with community-acquired pneumonia (CAP) | American Thoracic Society (ATS), 2025: Diagnosis and management of CAP | Newer focused update to the 2019 ATS/IDSA guideline. Covers lung ultrasound, viral-test-positive CAP, antibiotic duration, and corticosteroids. |
| Children >3 months with CAP | IDSA/PIDS, February 2026: Pediatric CAP guideline | Replaces the 2011 pediatric guideline. Includes diagnosis, treatment, and parapneumonic effusion/empyema. |
| Community- and hospital-acquired pneumonia, age >1 month | NICE NG250, last reviewed September 2025: Pneumonia diagnosis and management | Covers children and adults, CAP and HAP, including bacterial pneumonia after COVID-19. Does not cover VAP or COVID-19 pneumonia itself. |
| Adult pneumonia, including aspiration and healthcare-associated pneumonia | Japanese Respiratory Society Adult Pneumonia Practice Guideline 2024, published 2025 | Gives particular attention to older adults, aspiration pneumonia, prevention, rehabilitation, oral care, vaccination, and antibiotic stewardship. Practice Guideline . Tier 6 . 2025 [PMID: 40614556] |
| Adult CAP, France | SPILF/SPLF update, 2025 | National CAP update endorsed by French infectious disease, respiratory, ICU, microbiology, radiology, and emergency societies. Practice Guideline . Tier 6 . 2025 [PMID: 40031989] |
| Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) | ATS/IDSA 2016 guideline remains the current published US guideline: HAP/VAP guidance | A replacement ATS/IDSA HAP/VAP guideline is listed for expected publication in Q4 2026, so it is not yet available as of this date. |